Scoliosis screening is a public health strategy aimed at the early detection of spinal curvature abnormalities, especially *idiopathic scoliosis*, in asymptomatic children and adolescents.
β-
RΓos-de-Moya-Angeler et al. evaluate a scoliosis screening program (PANA) where attendance drops from 73.2% to 20.5% between age groups, and only 15.3% complete all phases 1)
Conclusion: Evaluating effectiveness in a system with near-zero adherence is methodologically meaningless.
β This is like reviewing the efficiency of a train that never arrives. β
From 881 initial subjects, only 127 were followed up β a biased 14.4%. Retrospective reliance on the visual forward bending test (FBT) without quantification undermines any clinical validity.
Red flag: You cannot draw robust conclusions from uncalibrated tools and a self-selected cohort.
Visual FBT had only 5.9% sensitivity, with 11.1% false positives at age 13-14. Only 4% were positive when using a scoliometer >7Β°.
β It takes 9 years to learn a basic lesson: use an instrument, not your eyes. β
The study calls for better-trained staff and use of the scoliometer in schools, but fails to address:
Policy fantasy: More of the same wonβt fix foundational flaws.
No data on:
Conclusion: The study is disconnected from real-world scoliosis management and decision-making.
This is not a validation β it is an autopsy. With no useful correlation to patient-centered outcomes, this study:
β Monitoring failure for a decade does not turn it into success. β